Eschwège E, Charles M A, Simon D, Thibult N, Balkau B
Faculty of Medicine, University of Paris XI, Villejuif, France.
Diabetes Care. 2001 Nov;24(11):1945-50. doi: 10.2337/diacare.24.11.1945.
To describe the characteristics and vital prognosis of men with diabetes diagnosed by one fasting plasma glucose (FPG) concentration > or =7.0 mmol/l, with diabetes diagnosed by one isolated postchallenge hyperglycemia (IPH) (FPG <7.0 mmol/l and a 2-h plasma glucose concentration > or =11.1 mmol/l), or with impaired glucose tolerance (IGT).
This study involved a cohort of 6,881 Caucasian nondiabetic men from the Paris Prospective Study, aged 44-55 years, who were followed for cause of death for 20 years.
Diabetes was diagnosed in 4.3% of the men (1.0% diabetes diagnosed by IPH), and IGT was diagnosed in 9% of the men. At baseline, the men with diabetes diagnosed by IPH had a lower cardiovascular risk profile than those with diabetes diagnosed by FPG, as did the men with IGT and a normal fasting glucose level (<6.1 mmol/l, IGT and normal fasting glucose), compared with men with impaired fasting glucose (6.1-6.9 mmol/l, IGT and impaired fasting glucose [IFG]). At 20 years of follow-up, all-cause and cancer death rates were higher in men with diabetes diagnosed by IPH than in men with diabetes diagnosed by FPG (55 vs. 44%, P < 0.1 and 31 vs. 17%, P < 0.01, respectively) but were not significantly different for coronary causes (6 vs. 11%). Men with IGT and normal fasting glucose also had significantly higher cancer death rates than men with IGT and IFG.
The most likely explanation for the high cancer and low coronary death rates is that men with diabetes diagnosed by IPH consumed alcohol; the men in this study drank 49 g of pure alcohol on average per day, equivalent to 0.6 l of wine. If these results are confirmed by other prospective studies, screening subjects for isolated postchallenge hyperglycemia may not be worthwhile.
描述空腹血糖(FPG)浓度≥7.0 mmol/l诊断为糖尿病的男性、单次口服葡萄糖耐量试验后血糖升高(IPH)(FPG<7.0 mmol/l且2小时血浆葡萄糖浓度≥11.1 mmol/l)诊断为糖尿病的男性或糖耐量受损(IGT)男性的特征及重要预后情况。
本研究纳入了巴黎前瞻性研究中的6881名44至55岁的非糖尿病白种男性队列,对其进行了20年的死因随访。
4.3%的男性被诊断为糖尿病(1.0%通过IPH诊断为糖尿病),9%的男性被诊断为IGT。在基线时,与空腹血糖受损(6.1 - 6.9 mmol/l,IGT且空腹血糖受损[IFG])的男性相比,通过IPH诊断为糖尿病的男性以及IGT且空腹血糖正常(<6.1 mmol/l,IGT且空腹血糖正常)的男性心血管风险状况较低。在随访20年后,通过IPH诊断为糖尿病的男性全因死亡率和癌症死亡率高于通过FPG诊断为糖尿病的男性(分别为55%对44%,P<0.1;31%对17%,P<0.01),但冠状动脉疾病导致的死亡率无显著差异(6%对11%)。IGT且空腹血糖正常的男性癌症死亡率也显著高于IGT且IFG的男性。
癌症死亡率高和冠状动脉疾病死亡率低的最可能解释是,通过IPH诊断为糖尿病的男性饮酒;本研究中的男性平均每天饮用49克纯酒精,相当于0.6升葡萄酒。如果这些结果得到其他前瞻性研究的证实,筛查单次口服葡萄糖耐量试验后血糖升高的受试者可能不值得。